Waltz Quoted in Compliance Week

San Francisco Partner Judith Waltz was quoted in an article titled “Sunshine Act Compliance Stymies Healthcare Firms” in the July 2013 issue of Compliance Week. The article discusses the impact the Sunshine Act will have on drug companies and medical equipment companies. Ms. Waltz was quoted saying, “This may relate to concerns about how their participation will be viewed by patients, or to the increasing prevalence of institutional policies that limit or even preclude involvement in any activity that might be viewed as a conflict of interest for clinical decision making. [If this trend continues,] it could result in some significant constrictions on future research and clinical discussion of existing drugs.”